Drug intelligence / Profile preview

anacardic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Anacardic acid is a natural bioactive phytochemical primarily derived from the shell of the cashew nut (*Anacardium occidentale*). Chemically, it is a salicylic acid derivative with a long aliphatic side chain. It is widely recognized in biochemical research as a potent, non-competitive inhibitor of histone acetyltransferases (HATs), specifically targeting p300 and CREB-binding protein (CBP). By inhibiting HAT activity, anacardic acid modulates epigenetic gene expression, leading to anti-proliferative and pro-apoptotic effects in various cancer models, including pancreatic, breast, and prostate cancers. Research has demonstrated that it can activate the ATM-p53 signaling pathway to induce cell cycle arrest. Additionally, anacardic acid exhibits anti-inflammatory properties by inhibiting NF-κB signaling and possesses antimicrobial and antioxidant activities. While it is not currently an approved pharmaceutical drug, it is studied as a lead compound for oncology and is found in some nutraceutical products.

Other names
2-hydroxy-6-pentadecylbenzoic acid6-pentadecylsalicylic acid6-pentadecyl-2-hydroxybenzoic acid
02

Targets

KAT2A (Lysine acetyltransferase 2A)CREBBP (CREB-binding protein)EP300 (Histone acetyltransferase p300)KAT2B

Beyond the preview

Go deeper on anacardic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anacardic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call